These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27180050)

  • 1. Structural and dynamic perspectives on the promiscuous transport activity of P-glycoprotein.
    Subramanian N; Condic-Jurkic K; O'Mara ML
    Neurochem Int; 2016 Sep; 98():146-52. PubMed ID: 27180050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
    Zhou Y; Gottesman MM; Pastan I
    Arch Biochem Biophys; 1999 Jul; 367(1):74-80. PubMed ID: 10375401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.
    Loo TW; Clarke DM
    J Membr Biol; 2005 Aug; 206(3):173-85. PubMed ID: 16456713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
    J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N; Giri N; Pan G; Elmquist WF
    Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single active catalytic site is sufficient to promote transport in P-glycoprotein.
    Bársony O; Szalóki G; Türk D; Tarapcsák S; Gutay-Tóth Z; Bacsó Z; Holb IJ; Székvölgyi L; Szabó G; Csanády L; Szakács G; Goda K
    Sci Rep; 2016 Apr; 6():24810. PubMed ID: 27117502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of the linker region in purified human P-glycoprotein.
    Sato T; Kodan A; Kimura Y; Ueda K; Nakatsu T; Kato H
    FEBS J; 2009 Jul; 276(13):3504-16. PubMed ID: 19490125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2.
    Shukla S; Sauna ZE; Ambudkar SV
    Leukemia; 2008 Feb; 22(2):445-7. PubMed ID: 17690695
    [No Abstract]   [Full Text] [Related]  

  • 9. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.
    Abulrob AG; Gumbleton M
    Biochem Biophys Res Commun; 1999 Aug; 262(1):121-6. PubMed ID: 10448079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.
    Jonker JW; Wagenaar E; van Deemter L; Gottschlich R; Bender HM; Dasenbrock J; Schinkel AH
    Br J Pharmacol; 1999 May; 127(1):43-50. PubMed ID: 10369454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism.
    Omote H; Al-Shawi MK
    Biophys J; 2006 Jun; 90(11):4046-59. PubMed ID: 16565061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
    Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A; Gutmann H; Drewe J
    Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
    Erić S; Kalinić M; Ilić K; Zloh M
    SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M; Suzuyama N; Takeuchi T; Yoshitomi S; Asahi S; Yokoi T
    J Pharm Sci; 2006 Dec; 95(12):2673-83. PubMed ID: 16892207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice.
    Brzozowska NI; Smith KL; Zhou C; Waters PM; Cavalcante LM; Abelev SV; Kuligowski M; Clarke DJ; Todd SM; Arnold JC
    Brain Behav Immun; 2017 Oct; 65():251-261. PubMed ID: 28502879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of an In-Cell Western for Quantifying P-Glycoprotein Expression in Human Brain Microvascular Endothelial (hCMEC/D3) Cells.
    McInerney MP; Pan Y; Short JL; Nicolazzo JA
    J Pharm Sci; 2017 Sep; 106(9):2614-2624. PubMed ID: 28065764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.